Therapeutic plasmapheresis in the therapy of neurological diseases - One center experience;Terapeutická plazmaferéza v lébě neurologických onemonění - Vlastní zkušenosti

Aktuality v Nefrologii

Volumn 16, Issue 2, 2010, Pages 44-50

  Lánská, Miriam ^a   Vališ, Miloslav ^b   Bláha, Milan ^a   Strnadová, Blažena ^a   Malý, Jaroslav ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b LF UK   (Czech Republic)

Author keywords

Extracorporeal elimination; Hemapheresis; Neurological diseases; Plasma exchange; Plasmapheresis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOTENSION; MALE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NEUROPATHY; PARESTHESIA; PLASMAPHERESIS; POLYRADICULITIS; SKIN ALLERGY;

EID: 77954575653     PISSN: 1210955X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Anonymous: Guidelines for documentation of therapeutic apheresis procedures in the medical record by apheresis physicians. J Clin Apher 2007; 22(3): 183-186.
2. Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z: Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial. 2005; 9: 391-5.
3. Bengsch S, Boos KS, Nagel D, Seidel D, Inthorn D: Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study. Shock 2005; 23(6): 494-500. (Pubitemid 40677420)
4. Bláha M, Blažek M, Bláha V, Cermanová M, Filip S, Andrýs C, Lánská M, Malý J: Terapeutická plazmaferéza a specifičtějš í metody extrakorporální eliminace cholesterolu. Aktuality v nefrologii 15; 2009: 154-158.
5. Bramlage CP, Schroder K, Bramlage P et al: Predictors of Complications in Therapeutic Plasma Exchange. Journal of Clinical Apheresis 2009; 24, 6: 225-231.
6. Ezer A, Caliskan K, Parlakgumus A et al: Preoperative Therapeutic Plasma Exchange in Patients With Thyrotoxicosis. Journal of Clinical Apheresis 2009; 24, 3: 111-114.
7. Kankirawatana S, Huang ST, Marques MB: Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange. Journal of Clinical Apheresis 2007; 22: 265-269. (Pubitemid 350013060)
8. Murai H, Arahata H, Osoegawa M et al: Effect of immunotherapy in myelitis with atopic diathesis. J Neurol Sci. 2004 Dec 15; 227(1): 39-47. (Pubitemid 39491124)
9. Novak DJ, Tyler LN, Reddy RL et al: Plasmapheresis and Intravenous Immune Globulin for the Treatment of D Alloimmunization in Pregnancy. Journal of Clinical Apheresis 2008; 23, 6: 183-185.
10. Shaz BH, Linenberger ML, Bandarenko N et al: Category IV indications for therapeutic apheresis - ASFA fourth special issue. Journal of Clinical Apheresis 2007; 22, 3: 176-180. (Pubitemid 47025121)
11. Shemin D, Briggs D, Greenan M: Complications of plasma exchange: A prospective study of 1727 procedures. J Clin Apher 22; 2007: 270-276. (Pubitemid 350013061)
12. Schröder A, Linker RA, Gold R: Plasmapheresis for neurological disorders. Expert Rev Neurother 2009;9:1331-9.
13. Schwab PJ, Fandy JL: Treatment of Waldenstrom macroglobulinemia by plasmapheresis. N Engl J Med. 1960; 263: 574-579.
14. Sivakumaran P, Vo AA, Villicana R et al: Therapeutic Plasma Exchange for Desensitization Prior to Transplantation in ABO-Incompatible Renal Allografts. Journal of Clinical Apheresis 2009; 24, 4: 155-160.
15. Sivakumaran P, Tabak SW, Gregory K et al: Management of Familial Hypertriglyceridemia During Pregnancy With Plasma Exchange. Journal of Clinical Apheresis 2009; 24, 1: 42-46.
16. Stegmayr BG, Ivanovich P, Korach JM et al: Conference Information: 10th Congress of the World-Apheresis-Association held at the 25th Annual Meeting of the American-Society-for-Apheresis, Date: MAY 05-08, 2004 Miami Beach FL. Journal of Clinical Apheresis 2005; 20, 2: 126-127.
17. Szczepiorkowski ZM, Bandarenko N, Kim HC et al: American Society for Apheresis: Apheresis Applications Committee of the American Society for Apheresis: Guidelines on the use of therapeutic apheresis in clinical practice: evidence - based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007; 22: 106-75.
18. Szczepiorkowski ZM, Bandarenko N, Kim HC et al: Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. Journal of clinical Apheresis 2007; 22, 3: 106-175. (Pubitemid 47025120)
19. Szczepiorkowski ZM, Shaz BH, Bandarenko N et al: The new approach to assignment of ASFA categories - Introduction to the fourth special issue: clinical Applications of therapeutic apheresis. Journal of Clinical Apheresis 2007; 22, 3: 96-105. (Pubitemid 47025119)
20. Szczepiorkowski ZM, Shaz BH, Bandarenko N, Winter JL: The New Approach to Assignment of ASFA. Categories - Introduction to the Fourth Special Issue: Clinical Applications of Therapeutic Apheresis. Journal of Clinical Apheresis 2007; 22: 96-105. (Pubitemid 47025119)
21. Weinstein R: Therapeutic apheresis in neurological disorders: a survey of the evidence in support of current category I a II indications for therapeutic plasma exchange. Ther Apher Dial. 23; 2008: 196-201.
22. Yeh JH, Cheby CK, Chiu HC: A case report of double-filtration Plasmapheresis for the treatment of age-related macular degeneration. Ther Apher Dial 2008; 12: 500-504.
23. Yeo FE, Bohen EM, Yuan CM et al: Therapeutic plasma exchange as a nephrological procedure: a single-center experience. J Clin Apher. 2005; 20, 4: 208-16.